6.9800
14-二月-25 11:21:10
15 分钟延时
股票
-0.2600
-3.59%
今日范围
6.9800 - 7.2100
ISIN
FR0012127173
来源
Cboe
OSE Immunotherapeutics Receives €8.4 M in Public Funding to Support the Registration Phase 3 Clinical Trial of Cancer Vaccine Tedopi® in Lung Cancer
10 4月 2024 12:00:00 条件 Nasdaq GlobeNewswire
OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology
02 4月 2024 01:30:00 条件 Nasdaq GlobeNewswire
OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update
27 3月 2024 13:00:00 条件 Nasdaq GlobeNewswire